question · deep · not yet written
Two published rates for antibodies against the Kymriah CAR, years apart
Sources from different years report different rates of antibodies against the mouse-derived part of the tisagenlecleucel CAR; no record says which is right.
Not yet written
This question is named but not yet researched. To write it, these must be answered:
- What rate does each source report, measured how, in which patients, and at what time after infusion?
- Is the difference a real change (assay, population, follow-up) or two ways of counting the same thing?
- Does either rate predict loss of response? Open the primary immunogenicity data, not a review.
Fields to fill: Observation, Hypotheses, What is missing, What is known, What is not, What would settle it, Who works on it.
Sources
None yet: nothing here has been researched.
History of this record (1)
This record has been changed 1 time, on the dates below. The note kept against each change is written for the people who maintain the atlas, in their own shorthand, so it is not shown here; it is in the record itself.
- Kind
- big-open
- Register
- open-question
- Triage
- needs-research
- Status
- not yet written
- Last updated
- 2026-11-17
- Record
- content/questions/kymriah-antibody-rate-disagreement.json